Cargando…

Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound

OBJECTIVES: To explore an optimal model to predict the response of patients with axillary lymph node (ALN) positive breast cancer to neoadjuvant chemotherapy (NAC) with machine learning using clinical and ultrasound-based radiomic features. METHODS: In this study, 1014 patients with ALN-positive bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Cao, Wen, Liu, Lianjuan, Meng, Zifan, Sun, Ningning, Meng, Yuanyuan, Fei, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201761/
https://www.ncbi.nlm.nih.gov/pubmed/37211604
http://dx.doi.org/10.1186/s12967-023-04201-8
_version_ 1785045321355624448
author Zhang, Hao
Cao, Wen
Liu, Lianjuan
Meng, Zifan
Sun, Ningning
Meng, Yuanyuan
Fei, Jie
author_facet Zhang, Hao
Cao, Wen
Liu, Lianjuan
Meng, Zifan
Sun, Ningning
Meng, Yuanyuan
Fei, Jie
author_sort Zhang, Hao
collection PubMed
description OBJECTIVES: To explore an optimal model to predict the response of patients with axillary lymph node (ALN) positive breast cancer to neoadjuvant chemotherapy (NAC) with machine learning using clinical and ultrasound-based radiomic features. METHODS: In this study, 1014 patients with ALN-positive breast cancer confirmed by histological examination and received preoperative NAC in the Affiliated Hospital of Qingdao University (QUH) and Qingdao Municipal Hospital (QMH) were included. Finally, 444 participants from QUH were divided into the training cohort (n = 310) and validation cohort (n = 134) based on the date of ultrasound examination. 81 participants from QMH were used to evaluate the external generalizability of our prediction models. A total of 1032 radiomic features of each ALN ultrasound image were extracted and used to establish the prediction models. The clinical model, radiomics model, and radiomics nomogram with clinical factors (RNWCF) were built. The performance of the models was assessed with respect to discrimination and clinical usefulness. RESULTS: Although the radiomics model did not show better predictive efficacy than the clinical model, the RNWCF showed favorable predictive efficacy in the training cohort (AUC, 0.855; 95% CI 0.817–0.893), the validation cohort (AUC, 0.882; 95% CI 0.834–0.928), and the external test cohort (AUC, 0.858; 95% CI 0.782–0.921) compared with the clinical factor model and radiomics model. CONCLUSIONS: The RNWCF, a noninvasive, preoperative prediction tool that incorporates a combination of clinical and radiomics features, showed favorable predictive efficacy for the response of node-positive breast cancer to NAC. Therefore, the RNWCF could serve as a potential noninvasive approach to assist personalized treatment strategies, guide ALN management, avoiding unnecessary ALND. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04201-8.
format Online
Article
Text
id pubmed-10201761
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102017612023-05-23 Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound Zhang, Hao Cao, Wen Liu, Lianjuan Meng, Zifan Sun, Ningning Meng, Yuanyuan Fei, Jie J Transl Med Research OBJECTIVES: To explore an optimal model to predict the response of patients with axillary lymph node (ALN) positive breast cancer to neoadjuvant chemotherapy (NAC) with machine learning using clinical and ultrasound-based radiomic features. METHODS: In this study, 1014 patients with ALN-positive breast cancer confirmed by histological examination and received preoperative NAC in the Affiliated Hospital of Qingdao University (QUH) and Qingdao Municipal Hospital (QMH) were included. Finally, 444 participants from QUH were divided into the training cohort (n = 310) and validation cohort (n = 134) based on the date of ultrasound examination. 81 participants from QMH were used to evaluate the external generalizability of our prediction models. A total of 1032 radiomic features of each ALN ultrasound image were extracted and used to establish the prediction models. The clinical model, radiomics model, and radiomics nomogram with clinical factors (RNWCF) were built. The performance of the models was assessed with respect to discrimination and clinical usefulness. RESULTS: Although the radiomics model did not show better predictive efficacy than the clinical model, the RNWCF showed favorable predictive efficacy in the training cohort (AUC, 0.855; 95% CI 0.817–0.893), the validation cohort (AUC, 0.882; 95% CI 0.834–0.928), and the external test cohort (AUC, 0.858; 95% CI 0.782–0.921) compared with the clinical factor model and radiomics model. CONCLUSIONS: The RNWCF, a noninvasive, preoperative prediction tool that incorporates a combination of clinical and radiomics features, showed favorable predictive efficacy for the response of node-positive breast cancer to NAC. Therefore, the RNWCF could serve as a potential noninvasive approach to assist personalized treatment strategies, guide ALN management, avoiding unnecessary ALND. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04201-8. BioMed Central 2023-05-21 /pmc/articles/PMC10201761/ /pubmed/37211604 http://dx.doi.org/10.1186/s12967-023-04201-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Hao
Cao, Wen
Liu, Lianjuan
Meng, Zifan
Sun, Ningning
Meng, Yuanyuan
Fei, Jie
Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
title Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
title_full Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
title_fullStr Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
title_full_unstemmed Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
title_short Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
title_sort noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201761/
https://www.ncbi.nlm.nih.gov/pubmed/37211604
http://dx.doi.org/10.1186/s12967-023-04201-8
work_keys_str_mv AT zhanghao noninvasivepredictionofnodepositivebreastcancerresponsetopresurgicalneoadjuvantchemotherapytherapybasedonmachinelearningofaxillarylymphnodeultrasound
AT caowen noninvasivepredictionofnodepositivebreastcancerresponsetopresurgicalneoadjuvantchemotherapytherapybasedonmachinelearningofaxillarylymphnodeultrasound
AT liulianjuan noninvasivepredictionofnodepositivebreastcancerresponsetopresurgicalneoadjuvantchemotherapytherapybasedonmachinelearningofaxillarylymphnodeultrasound
AT mengzifan noninvasivepredictionofnodepositivebreastcancerresponsetopresurgicalneoadjuvantchemotherapytherapybasedonmachinelearningofaxillarylymphnodeultrasound
AT sunningning noninvasivepredictionofnodepositivebreastcancerresponsetopresurgicalneoadjuvantchemotherapytherapybasedonmachinelearningofaxillarylymphnodeultrasound
AT mengyuanyuan noninvasivepredictionofnodepositivebreastcancerresponsetopresurgicalneoadjuvantchemotherapytherapybasedonmachinelearningofaxillarylymphnodeultrasound
AT feijie noninvasivepredictionofnodepositivebreastcancerresponsetopresurgicalneoadjuvantchemotherapytherapybasedonmachinelearningofaxillarylymphnodeultrasound